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The ineﬀective short-term control of feeding behavior compromises energy homeostasis and can lead to obesity. The
gastrointestinal tract secretes several regulatory peptides. However, little is known about the stomach peptide contribution to
the acute regulation of intake. In an attempt to identify new gastric signals, the serial analysis of gene expression (SAGE) method
was used for the transcription proﬁling of stomach mucosa in 7 groups of mice: fasting and sacriﬁced 30 minutes, 1 hour, 3
hours after a low-fat (LF) or high-fat (HF) ad libitum meal. In total, 35 genes were diﬀerentially modulated by LF and HF meals
compared to fasting, including 15 mRNAs coding for digestive enzymes/secretory proteins, and 10 novel transcripts. Although the
basic expression proﬁle did not undergo substantial variations, both LF and HF meals inﬂuenced the transcription. This study
represents the ﬁrst global analysis of stomach transcriptome as induced by diﬀerent nutritional stimuli. Further studies including
the characterization of novel genes may help to identify new targets for the therapy and prevention of obesity.
1.Introduction
Obesity epidemic continues its worrying global progression
although signiﬁcant advances have been achieved in the
knowledge of its causes and consequences. This condition,
in concert with glucose intolerance/type 2 diabetes, dyslipi-
demia, and metabolic syndrome, widely contributes to what
has been recently deﬁned as “prosperity’s plague” [1]. A
complex system of social, psychological, physiological, and
biologicalfactorshastobeconsideredinordertosuccessfully
control this “plague” and prevent from its further spread
[2, 3]. From a physiological point of view, it is fundamental
to understand the speciﬁc relative importance of long-term
and short-term mechanisms involved in the regulation of
energy balance [4]. Food intake and daily overconsumption
may have a predominant impact on body weight regulation,
and this led large interest to focus on appetite/satiety balance
as one of the key potential therapeutic targets [5]. Multiple
sites in the gastrointestinal (GI) tract, including the stomach,
proximal and distal small intestine, colon, and pancreas, are
involved in the short-term regulation of energy homeostasis,
which basically controls what, when, and how much we
eat within a single day or a single meal [6]. In addition to
mechanoreceptors and chemoreceptors, which are activated
during a meal and signal to the brainstem through the vagal
nerve [4], several gut-derived peptides and lipid mediators
have a role in the regulation of food intake and energy
homeostasis [7]. The only recognized “hunger” gut peptide
so far discovered is ghrelin. This peptide is mainly produced
by the stomach and directly inﬂuences the number of meals
consumed per day though it has probably no direct eﬀect
on meal size [8]. However, the stomach plays an essential
mechanical role in the regulation of satiety perception
and meal termination. It is, in fact, the ﬁrst organ to
receive the bolus of food. Here, the food ingested is rapidly
homogenized, partially digested, and ﬁnally delivered to the
small intestine. Importantly, gastric distension and gastric
emptying via the pylorus are ﬁnely regulated in order to
matchfooddeliverytotheactualgutdigestiveandabsorptive
capacity [9]. As a consequence, gastric competence can be
considered as the ﬁrst limiting step of GI ingestive and diges-
tive capacity and thus represents a relevant target for obesity2 Journal of Obesity
Table 1: Transcripts coding for digestive and secretory proteins diﬀerentially modulated by feeding in the gastric mucosa.
Tag Fasting
Low fat High fat
Description
3 0 m i n1 h 3 h3 0 m i n1 h 3 h
Digestive enzymes
CTGACTCAAAA 713 86 ↓ 48 ↓ 2020 ↑ 383 ∗ 106 ↓ 70 ↓ ∗ Amylase 2a1, pancreatic
(Mm.439729; NM 001042712)
CCCTGGGTTCA 130 4 ↓ 2 ↓ 353 ↑ 72 ∗ 14 ↓ 0 ↓ ∗ Chymotrypsinogen B1
(Mm.34374; BC061083)
TTAGGAGGCTG 164 11 ↓ 6 ↓ 346 72 ∗ 12 ↓ 2 ↓ ∗ Pancreatic lipase (Mm.20407;
NM 026925)
GGCTGTAATGT 65 6 ↓ 6 ↓ 175 52 ∗ 8 ↓ 7 ↓ ∗ Elastase 1, pancreatic (Mm.2131;
NM 033612)
GTGTGCGCCGG 61 4 ↓ 2 ↓ 117 32 2 ↓ 0 ↓ ∗ Elastase 3, pancreatic
(Mm.297477; BC061066)
TTCTGTCTGGG 51 0 ↓ 6 ↓ 102 18 2 ↓ 0 ↓ ∗
Trypsinogen 7 ( RIKEN cDNA
2210010C04 gene;
Mm.153729; BC061093)
CCCGGGTGCAA 0 4 4 36 ↑ 80 2 ∗ Pancreatic lipase related protein
1 (Mm.10753; BC068266).
GACCACACTGT 35 6 0 ↓ 109 28 10 0 ↓ ∗ Carboxypeptidase A1
(Mm.25377; BC052661)
GAGCACGTACG 14 0 0 36 4 0 0 ∗ Carboxypeptidase A2, pancreatic
(Mm.268855; NM 001024698)
ATCTGTGTTGG 193 27 ↓ 31 ↓ 317 68 37 ↓ 25 ↓ ∗
Protease serine 2 (Mm.276926;
NM 009430)/Trypsin 4
(Mm.383263; NM 011646)
GCCTACAACTA 30 0 ↓ 4 113 ↑ 16 2 ↓ 0 ↓ ∗ Chymotrypsin-like (Mm.2745;
NM 023182)
GCACCAAGTAC 26 0 ↓ 0 ↓ 98 ↑ 16 2 2 ∗ EST Carboxypeptidase B1
(Mm.34692; CF577795)
CAGACTAAGTA 24 4 2 122 ↑ 26 0 ↓ 2 Carboxyl ester lipase
(Mm.236017; NM 009885)
Exocytosis/secretory
pathways
GCAAGACCCGC 26 2 0 ↓ 49 16 2 5 ∗ Syncollin (Mm.25210;
NM 026716)
AAAGTATGCAA 122 25 ↓ 37 ↓ 98 72 37 ↓ 34 ↓
Zymogen granule membrane
protein 16 (RIKEN cDNA
1810010M01 gene; Mm.21835;
BC031800)
Numbers indicate the count of serial analysis of gene expression (SAGE) tags per 50000.
↑↓ indicate a signiﬁcant diﬀerential regulation by LF or HF feeding compared to fasting (P ≤ .05).
∗ indicates the signiﬁcant modulation in the HF compared to the LF group at the corresponding time point (P ≤ .05).
preventionandtreatment.Motilityandphysicalmechanisms
involved in gastric-mediated satiety have been extensively
studied and successfully targeted in recent years [10, 11].
However, it is still unknown whether the gastric mucosa also
releases any biochemical signal that may inﬂuence satiety in
the very short term of meal consumption. In an attempt to
explore this possibility, the serial analysis of gene expression
(SAGE)methodwasusedtoidentifytheearlytranscriptional
changes induced by a low-fat (LF) or high-fat (HF) meal
in the gastric mucosa. The discovery potential of SAGE
was determinant for choosing this technology instead of
other comparable transcriptomic methods. SAGE, indeed,
is a powerful and reliable sequencing-based technique [12]
which allows to detect the regulation of novel transcripts as
well as characterized genes, as we have already shown in a
number of previous studies [13, 14].
2.MaterialsandMethods
2.1. Animals, Diet, and Sample Preparation. A total of 140
male C57BL6 mice (12-week-old) were purchased from
Charles River Canada Inc. and were acclimated for two
weeks. Low-fat diet (LF, Research Diet no. 12450B: 10%
calories from fat, 70% from carbohydrate, and 20% from
protein; 3.85kcal/g) and tap water were served ad libitum.
In the last day of the acclimatization, the body weightJournal of Obesity 3
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Figure 1:Foodandenergyintakeoflow-fatandhigh-fatmeals:cumulative(a,b)and30minutesaverage(c,d)measurements. ∗Signiﬁcantly
diﬀerent compared to low-fat (LF) meal at the same time point (P<. 05). § Signiﬁcant eﬀect of the diet (P<. 05). Abbreviations: g, grams;
kcal, kilocalories; LF, low fat; HF, high fat.
paired mice were randomly distributed into seven groups
and fasted for 12 hours during darkness of the light cycle.
On the experimental day, one group of fasted mice was
sacriﬁced before the meal. The other mice were fed ad
libitum with high-fat (HF, Research Diet no. 12492: 60%
calories from fat, 20% from carbohydrate, and 20% from
protein; 5.24kcal/g) or LF meal and sacriﬁced 30min, 1h,
and 3h after the beginning of the meal. The amount of
macronutrients and energy ingested was recorded. In total,
seven groups of mice under isoﬂurane anesthesia (fasting,
HF 30min/1h/3h, and LF 30min/1h/3h) were alternatively
exsanguinated by cardiac puncture after cervical dislocation.
Stomach was opened vertically and ﬂushed clean with saline,
and the mucosa was removed by scrapping with a glass
microscope slide. The samples were rapidly frozen in liquid
nitrogen and stored at −80◦C until RNA extraction. All
animal experimentation was conducted in accordance with
the requirements of the Canadian Council on Animal Care
and approved by the Animal Protection Committee of Laval
University.
2.2. Transcriptomic Analysis. The seven serial analyses of
gene expression (SAGE) libraries were constructed as previ-
ously described [15]. Total RNA was isolated from pooled
stomach mucosa for each group (n = 20) by Trizol
(Invitrogen Canada Inc., Burlington, ON). The quality of
total RNA was monitored by microcapillary electrophoresis
(Bioanalizer 2100, Agilent Technologies, Mississauga, ON).
Polyadenylated RNA was extracted (Oligotex mRNA Mini
Kit,QiagenInc.,Mississauga,ON),annealedwiththebiotin-
5 -T18-3  primer, and converted to cDNA (cDNA synthesis
kit, Invitrogen Canada Inc.). The resulting cDNAs were
digested with NlaIII (New England BioLabs Ltd., Pickering,
ON), and the 3  restriction fragments were isolated with
streptavidin-coated magnetic beads (Dynal Biotech LLC,
Brown Deer, WI) and separated into two populations. Each
population was ligated to one of two annealed linkers and
extensively washed to remove unligated linkers [15]. The tag
besidethemost3 NlaIII restrictionsite(CATG)ofeachtran-
script was released by digestion with BsmFI (New England
BioLabs Ltd.). The blunting kit from Takara Bio Inc. (Otsu,
Japan) was used for the blunting and ligation of the two
tag populations. The resulting ligation products containing
the ditags were ampliﬁed by PCR and digested with NlaIII.
The band containing the ditags was extracted from the 12%
polyacrylamide gel. The puriﬁed ditags were self-ligated to
form concatemers using T4 ligase (Invitrogen Canada Inc.).
The isolated 500bp to 1800bp concatemers were isolated by4 Journal of Obesity
Table 2: Transcripts with defence/protection roles and other genes diﬀerentially modulated by feeding in the gastric mucosa.
Tag Fasting
Low fat High fat
Description
30min 1h 3h 30min 1h 3h
Cellular defence/
Protein modiﬁcation
CCAGGCCTTAC 53 23 44 11 ↓ 44 47 32 Cysteine-rich protein 1
(Mm.272368; NM 007763)
TGTTCAGTTTT 0 2 23 ↑ 008 0 Heat shock protein 1A-Hsp70
1A (Mm.6388; BC054782)
TCTACACTGCC 0 15 56 ↑ 71 0 45 ↑ 0
EST Heat shock protein
1B-Hsp70 1B (Mm.372314;
BP766094)
TAACTGACAAT 91 38 37 26 ↓ 64 66 43
Metallothionein 2
(Mm.147226; BC031758)/EST
Phosphatidylinositol-4-
phosphate 5-kinase, type 1
alpha-Pip5k1a (Mm.296409;
BU744153)
AACGCTTTCTA 81 27 46 33 34 45 11 ↓ Placenta-speciﬁc 8 (onzin)
(Mm.34609; BC010789)
CAGGAGGAGTT 28 13 21 18 22 4 41 ∗
Protein disulﬁde isomerase
associated 3 (Mm.263177;
BC033439)
GTGTGCGCTGG 10 0 0 38 6 0 0 ∗
EST Elastase 2A (Neutrophil
elastase) (Mm.45316;
BM730866)
TCGCTGCTTTA 75 44 40 11 ↓ 24 23 25 EST WD repeat domain 92
(Mm.298132; CO039767)
Regulatory mechanisms
TATTTCAGTGA 0 6 8 27 ↑ 12 6 5 Adenylate cyclase 6
(Mm.157091; NM 007405)
GGCTGTCCTGT 0 2 15 13 2 6 25 ↑
DEAD (Asp-Glu-Ala-Asp)
box polypeptide 17
(Mm.29644; BC096036)
TCCTGAAGAGG 2 8 31 ↑ 13 12 16 16
Furin (paired basic amino
acid cleaving enzyme)
(Mm.5241; BC048234)
AATTTCTTCCT 24 67 12 26 8 ∗ 18 2
Major urinary protein 1/2
(Mm.335875; BC099597);
(Mm.457981; AC:BC012259).
CAGCAAATGAA 6 6 0 33 4 2 0 ∗ EST Kallikrein 1 (Mm.142722;
BG871914)
Others
AAAAATCATCG 22 4 67 62 62 76 93 ↑
NADH dehydrogenase 5,
mt-Nd5 (CDNA clone
IMAGE: 4910858;
Mm.455357; BC055066)
GACCTGGAGCC 30 23 8 2 ↓ 14 6 7 EST Ribosomal protein S14
(Mm.43778; AV212419)
Numbers indicate the count of serial analysis of gene expression (SAGE) tags per 50000.
↑↓ indicate a signiﬁcant diﬀerential regulation by LF or HF feeding compared to fasting (P ≤ .05).
∗ indicates the signiﬁcant modulation in the HF compared to the LF group at the corresponding time point (P ≤ .05).
agarose gel, and the resulting DNA fragments were ligated
into the SphI site of pUC19 and cloned into OmniMAX 2T1
competent cells (Invitrogen Canada Inc.). White colonies
were picked up, and the concatemer inserts were ﬁnally
sequenced by the Applied Biosystems 3730 (Foster City, CA).
2.3. Bioinformatic Analysis. Sequence ﬁles were analyzed
using the SAGEana program, a modiﬁcation of SAGEparser
[12].Identiﬁcationofthetranscriptswasobtainedbymatch-
ing the 15bp (sequence at the last CATG+11bp tags) with
SAGEmap, UniGene, and GenBank databases. ClassiﬁcationJournal of Obesity 5
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Figure 2: Thirty minutes average nutrient intake (a, b, c) and the correspondent digestive enzyme-coding gene fold-change regulation by
feeding (d, e, f). ∗Signiﬁcantly diﬀerent compared to low-fat (LF) meal at the same time point (P<. 05). § Signiﬁcant eﬀect of the diet
(P<. 05). Abbreviations: g, grams; LF, low fat; HF, high fat.
of the transcripts was based upon the updated information
of the genome directory [16] found at the TIGR website
(http://www.tigr.org/), the SOURCE (http://genome-www5.
stanford.edu/cgi-bin/source/sourceSearch), and the OMIM
(http://www.ncbi.nlm.nih.gov/)a sw e l la sp r e v i o u s l yp u b -
lished literatures. We have previously shown that the SAGE
method is very reproducible with r2 = 0.96 between two
SAGE libraries constructed from the same total RNA pool
[12].
2.4. Validation by Quantitative Real-Time PCR (Q RT-PCR).
First strand cDNA was synthesized using 5μgo fp o o l e dR N A
of each experimental group in a reaction containing 200U of
Superscript III Rnase H-RT (Invitrogen Canada Inc.), 50ng
of random hexamers, 300ng of oligo-dT18,5 0 m MT r i s -
H C lp H8 . 3 ,7 5m MK C l ,3m MM g C l 2, 5mM dithiothreitol,
0.5mM deoxynucleotides triphosphate, and 40U human
RNase inhibitor (Roche) in a ﬁnal volume of 50μL. The
resulting products were then treated with 1μg of Rnase A
for 30 minutes at 37◦C and puriﬁed thereafter with Qiaquick
PCR puriﬁcation kits (Qiagen). The cDNA corresponding
to 20ng of total RNA was used to perform ﬂuorescent-
based real-time PCR quantiﬁcation using the LightCycler
real-time PCR apparatus (Roche Inc., Nutley, NJ) and the
FastStart DNA Master SYBR green kit (Roche Diagnostics).
Quantiﬁcations were conducted in triplicates. Reading of the
ﬂuorescence signal was taken at the end of the heating to
avoid nonspeciﬁc signal. A melting curve was performed
to assess nonspeciﬁc signals. Annealing temperature was
selected based on contamination levels and melting curve
results. Prior to mRNA quantiﬁcation, RNA samples were
also veriﬁed for genomic DNA contamination. Oligoprimer
pairs that allow the ampliﬁcation of approximately 250bp
were designed by GeneTools software (Biotools Inc., Edmon-
ton, AB) and their speciﬁcity was veriﬁed by BLAST in
GenBank database. Gene name, GenBank accession num-
bers, and regions used for the primer pairs were the
following: chymotrypsin-like elastase family member 3B
(elastase 3, Cela3b), NM 026419, 189–385; amylase 2a1,
pancreatic (Amy2a1), NM 001042712, 848–1039; pancreatic
lipase (Pnlip), NM 026925, 840–1067; major urinary protein
1( M u p 1 ) ,NM 031188, 127–405; protein disulﬁde isomerase
associated 3 (Pdia3), BC033439, 994–1222; zymogen granule
membrane protein 16 (Zg16), NM 026918, 348–522. The
mRNA levels were calculated using a standard curve of
crossing point (Cp) versus logarithm of the quantity and
expressed as the number of copies per microgram of total
RNA [17]. The LightCycler 3.5 program provided by the
manufacturer (Roche Inc.) was used to calculate the Cp
according to the second derivative and double-correction
method previously described by Luu-The et al. [17]. The
standard curve with eﬃciency coeﬃcient E = 2w a s
established using known cDNA amounts of 0, 102,1 0 3,1 0 4,
105,a n d1 0 6 copies of ATP synthase O subunit.6 Journal of Obesity
2.5. Statistical Analysis. Food and macronutrient intakes
were analyzed by the two-way ANOVA. When the ANOVA
revealed a signiﬁcant interaction between diet and time, the
contrast analysis was performed to identify the signiﬁcant
diﬀerencebetweentheHFandLFgroupsfromthesametime
points (P<. 05). For the SAGE data, the comparative count
display (CCD) test was used to identify the transcripts which
were signiﬁcantly diﬀerentially expressed (P ≤ .05) between
the groups with more than a two-fold change, as previously
described by Lash et al. [18] .T h ed a t aw e r en o r m a l i z e dt o
50000 tags for presentation. Q RT-PCR data were analyzed
bythetwo-tailedStudent’st-test(P<. 01)forthetimepoints
formerly determined by the SAGE method.
3. Results
3.1. Food Intake. Food and energy intakes are presented in
Figure1ascumulative and30minutes averageconsumption.
As expected, cumulative energy as well as protein and fat
intakes were higher, whereas carbohydrate intake was lower
intheHFgroupscomparedtoLF(Figure2(a)).Interestingly,
a distinct pattern of feeding behavior between LF- and HF-
fed mice can be observed by comparing the average 30
minutes consumption of the two groups (Figure 1(c)). Mice
assigned to LF meal ate a moderate amount of food during
one hour, after which their consumption decreased to a
minimum intake. In contrast, the HF group consumed a
large amount of meal in the ﬁrst 30 minutes although the
intake dropped in the following 30 minutes, reaching the
minimumlevelat1h.However,theHF-groupmiceingestion
increased again in the last two hours.
3.2. Transcriptomic Analysis. Seven SAGE libraries were
generated to identify the transcripts diﬀerentially modulated
in mouse gastric mucosa by the following experimental
conditions: fasting; LF or HF meal at 30min, 1h and 3h
since the beginning of consumption (LF 30m/1h/3h and
HF 30m/1h/3h, resp.). Among the 56382 SAGE tag species
detected, a total of 35 transcripts were signiﬁcantly regulated
by LF and HF feeding compared to fasting, whereas 19 were
speciﬁcally modulated by HF compared to LF.
3.2.1. Transcripts Coding for Digestive/Secretory Proteins.
The most represented group includes transcripts coding
for digestive enzymes and secretory pathway components
(Table 1). Among the modulated mRNAs were amylase 2a1,
pancreatic lipase, carboxyl ester lipase, elastase 1 and 3, and
carboxypeptidase A1 and B1. Globally, three of them have
lipolytic functions, nine code for proteolytic enzymes and
one gene is involved in carbohydrate digestion. In addition,
two genes involved in zymogen granule secretion were
regulated,namelysyncollinandzymogengranulemembrane
protein 16. Interestingly, most of these genes showed a
common pattern of regulation since their expression was
d o w n r e g u l a t e da tL F3 0 ma n d1 h ,a sw e l la sa tH F1 h
and 3h, compared to fasting. Moreover, the expression of
these transcripts tended to increase at LF 3h though the up-
regulation was statistically signiﬁcant only for six of them,
such as amylase 2a1, chymotrypsinogen B1, and pancreatic
lipase related protein 1. Remarkably, for 13 out of the 15
tags considered, the speciﬁc diﬀerential regulation between
LF 3h and HF 3h achieved statistical signiﬁcance. There
is, therefore, a common downregulation of these transcripts
following both LF and HF feeding although a temporal delay
betweenthetwogroupscanbeobserved.Inaddition,3hours
after the beginning of the LF meal, their transcription tended
to increase at higher levels than those observed at the fasting
state.
3.2.2. Cellular Defence Related and Other Transcripts Diﬀer-
entially Regulated by Feeding. Feeding signiﬁcantly regulated
eight transcripts with protective roles (Table 2). Among
these, the mRNAs coding for the heat shock protein 70
(Hsp70) 1A and expressed sequence tag (EST) Hsp70 1B
were both upregulated by the LF meal, and the latter also
by the HF meal, at 1h following the beginning of ingestion.
Gene expressions of cysteine-rich protein 1, metallothionein
2, and EST WD repeat domain 92 were reduced at LF
3h compared to fasting, whereas onzin mRNA levels sig-
niﬁcantly decreased at HF 3h. Moreover, HF speciﬁcally
modulated the transcription of protein disulﬁde isomerase
associated 3 and EST elastase 2A/neutrophil elastase, respec-
tively, up- and downregulated at 3h.
The results also showed the diﬀerential regulation of
two transcripts coding for proprotein convertase proteins
(furin and kallikrein) and an interesting new candidate
as potential regulator of energy metabolism, namely Mup
1( T a b l e2). In addition, LF and HF feeding signiﬁcantly
regulated 12 novel transcripts with no match in public
databases (Table 3). In particular, the tags GGAGAACAGCG
and CTGACTCAAAT were speciﬁcally modulated by HF
feeding compared to LF and could represent potential targets
for further characterization studies.
3.3.Q RT-PCRConﬁrmationofSAGEResults. Tovalidatethe
SAGE results, the Q RT-PCR analysis was also performed
for some of the genes diﬀerentially regulated by feeding.
The chosen genes are representative of the functional groups
discussed. As presented in Figure 3, the Q RT-PCR results
globally conﬁrmed the changes in expression level as well as
the signiﬁcant modulation highlighted by the SAGE method.
4. Discussion
4.1. Fasting and Feeding States Modulated Pancreas-Related
Genes in the Stomach. The main regulated functional group
is represented by digestive enzyme-coding genes, many of
whicharemostlyexpressedbythepancreas[19].Inaddition,
two transcripts involved in the secretory pathway, syncollin,
and zymogen granule membrane protein 16 were also mod-
ulated. Many of the physiological changes induced by food
intake should arise within minutes. Therefore, the digestive
enzymes and regulatory factors are normally synthesized and
packedinsecretorygranulesatrest,readytobereleasedwhen
food ingestion and appropriate neurohumoral stimuli occur.
Following the meal, another cycle of synthesis and packagingJournal of Obesity 7
Table 3: Novel transcripts diﬀerentially modulated by feeding in the gastric mucosa.
Tag Fasting Low fat High fat
3 0 m i n1 h3 h3 0 m i n1 h3 h
TTGTTGCTACT 26 13 19 13 16 0 ↓ 11
GGAGAACAGCG 10 15 13 5 4 0 29 ∗
CTGACTCAAAT 4 0 4 26 4 0 0 ∗
TCCTATTAAGC 4 38 ↑ 37 ↑ 22 18 35 ↑ 23
TTGGGGGAGGG 10 36 19 16 16 23 61 ↑
CCTGCCCAGTA 10 29 42 40 14 ↑ 14 61 ↑
TACCATATACT 22 25 4 0 ↓ 42 0 2
TCTATGTCAGG 2 8 29 ↑ 96 1 2 2
GTGTCTGGTAA 24 32 89 ↑ 62 56 35 43
CACAAACATAT 0 13 8 24 ↑ 10 8 14
CGAACAAAAGA 2 29 ↑ 19 18 24 18 14
CCAGCAATCTT 18 67 85 ↑ 51 82 ↑ 64 45
Numbers indicate the count of serial analysis of gene expression (SAGE) tags per 50000.
↑↓ indicate a signiﬁcant diﬀerential regulation by LF or HF feeding compared to fasting (P ≤ .05).
∗ indicates the signiﬁcant modulation in the HF compared to the LF group at the corresponding time point (P ≤ .05).
prepares the zymogenic cells to the next secretory events
[9]. Concordantly, the present results showed a decreased
transcriptionofdigestiveenzyme-codingandsecretorygenes
followingthestartofingestion, whenthecellsaremorelikely
to invest energy in secretion. Moreover, in the LF-fed mice,
the reinduction of these genes that occurred 3 hours after
thebeginningofintakeseemsareasonableevent,particularly
if referred to their feeding pattern (Figure 2). Conversely,
the digestion of a high-calorie and high-energy density
meal, including its rate of emptying from the stomach,
normally takes a longer time to be accomplished [20, 21].
The latter point may explain the delayed and prolonged
downregulation of digestive transcripts in the HF group,
which also suggests that the reinduction of transcription
observed at LF 3h may have started later in the HF-fed mice.
Interestingly, though all the mice had ad libitum access to
food, feeding behavior and total ingestion were dissimilar
between LF and HF groups (Figures 1 and 2), possibly
explaining the diﬀerences in the transcriptional regulation of
digestive enzymes. However, the levels of digestive enzymes
and secretory proteins might as well inﬂuence the intake.
A physiological redundant excess of digestive capacity char-
acterizes the GI system and guarantees the eﬀectiveness of
nutrition. Moreover, the excess capacity for nutrient uptake,
including the excess of surface, specialized cells, digestive
enzymes, and other secretory products, is proportionally
related to body weight [9].Hence,thismayalsocontributeto
compromise the eﬃcient control of appetite/satiety balance
inoverweightandobesesubjects.Thestomachmayrepresent
a primary target for the control of meal size and satiation.
Eventually, surgical options which physically aﬀect gastric
capacity and emptying mechanisms successfully modify the
eating behavior and metabolic proﬁle of obese patients [10]
though they still are invasive and lifestyle-aﬀecting methods
[22]. Likewise, mechanisms other than mechanical may also
aﬀect gastric volume and emptying rates to regulate satiation
during meal consumption. Presently, there still is a paucity
of literature addressing the speciﬁc eﬀects of HF intake on
the neurohormonal control of gastric capacity and motility
mechanisms. Therefore, the search for these pathways was
the principal aim of the current study.
4.2. Plausible Reasons for the Expression of Pancreatic Genes
in the Stomach. The observation that gastric mucosa could
express pancreatic genes was unexpected. In particular, it
would be useful to explain the speciﬁc role of these genes
in the stomach and, most interestingly, their diﬀerential
regulation in response to fasting and feeding. Considering
the high level of transcription, such as for amylase 2a1 at
fasting and LF 3h, the expression of these genes should
entail a needed role in gastric mucosa. In contrast, it is hard
to explain how the digestive enzymes, normally active at a
neutral pH, could conceivably work in such an acidic milieu.
However, it should also be considered that these proteins
are often released as precursors and eventually activated by
speciﬁc signals or the appropriate pH.
Thiswasnottheﬁrsttimethattheexpressionandactivity
of pancreas-related genes were detected in the stomach and
other nonpancreatic components of the GI system. Terada
and colleagues [19] had already showed the expression of
alpha-amylase, trypsin, chymotrypsin, and pancreatic lipase
in normal and pathologic epithelial cells of gastric mucosa
by immunohistochemistry and western blotting. They had
also proved their enzymatic activity in stomach specimens,
althoughtoafarlesserextentthaninpancreas.Inthatreport,
the authors explained the presence of pancreatic enzymes in
nonpancreatic tissues as a result of the common embryonic
origin (foregut) shared by the gastroenteric tissues. In addi-
tion,themRNAexpressionlevelsofrepresentativegeneshave
been further conﬁrmed by Q RT-PCR in the present study.
It can be hypothesized that the digestive enzymes expressed
by the gastric mucosa would combine with the bolus of
homogenized and partially digested food that ﬁnally reaches
the small intestine. In normal conditions, the digestive8 Journal of Obesity
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Figure 3: Serial analysis of gene expression (SAGE) and quantitative real-time PCR (Q RT-PCR) results for some representative regulated
genes. ∗Signiﬁcantly diﬀerent compared to fasting (P<. 01). § Signiﬁcantly diﬀerent compared to low-fat (LF) meal at the same time point
(P<. 01). Abbreviations: LF, low fat; HF, high fat.
enzymes would be in excess, but enough to guarantee the
eﬀectiveness of digestion in case of insuﬃcient pancreatic
secretion. The redundant production of these proteins along
thedigestivetractwasalsosuggestedbyourpreviousstudyof
the duodenum transcriptome, where analogue experimental
conditions had been applied. In the intestine, the same
pancreas-related transcripts were modulated (n = 9) [13]
but showed the opposite trend, being upregulated at LF
1h and HF 3h. Interestingly, in both the duodenal and
gastric mucosa, the regulation of digestive gene expres-
sion presented a temporal delay between the LF and HF
groups.
4.3. LF and HF Modulated Genes Involved in the Protection
and Defense of Gastric Mucosa. Protection is one of the
main functions and challenges of gastric mucosa. The
mucosal epithelium is a primary barrier, which defends the
whole organism from external dangerous agents eventually
ingested. Moreover, uncontrolled acid secretion, inﬂam-
mation, oxidative stress, and the epithelial damages con-
sequently engendered can compromise the physical and
functional integrity of the mucosal barrier [23]. Among
the transcripts diﬀerentially regulated in the gastric mucosa,
seven were related to defense and protection. Metalloth-
ionein 2 [24, 25], Hsp70 (1A and 1B) [26, 27], and protein
disulﬁde isomerase associated 3 genes [28, 29]c o d ef o r
multiple-task proteins, which can show chaperone activity
and/or be involved in cell redox homeostasis control and
apoptosis regulation. The latter is a very important role,
since gastric epithelium is subject to constant renewal.
The epithelial cells, in fact, rapidly turnover (1–3 days in
humans), undergoing a cycle of division and diﬀerentiation
before succumbing to apoptosis [9, 30]. In this study, EST
Hsp70 1B was upregulated by both LF and HF at 1h, and
the same trend was observed for hsp70 1A. However, for
the latter, the HF 1h increase did not reach a statistical
signiﬁcance. Interestingly, a polymorphism of Hsp70 1B
gene has been recently associated with obesity-related traits
[31], thus stimulating further questions about its acute
modulation by food intake.
4.4. Mup1, Already Found in Hypothalamus and Duodenum,
was Expressed in the Gastric Mucosa and Regulated by
Feeding. In the present study, the gene coding for Mup1
was speciﬁcally downregulated at HF 30m compared to
LF. In previous transcriptomic studies conducted with theJournal of Obesity 9
SAGE method, Mup1 gene was also signiﬁcantly regulated
by feeding in the duodenum mucosa and hypothalamus of
mice [13, 14]. The corresponding protein is a pheromone
transporter normally expressed by the liver. However, recent
studies in mice have surprisingly revealed that Mup1 is also
involved in glucose and lipid metabolism [32], and that it
might play an important role in the regulation of energy
expenditure [33]. These ﬁndings raise the interest about the
speciﬁc role of this molecule at the tissue level but also as a
potential modulator of energy balance.
4.5. Other Interesting Genes Diﬀerentially Regulated by
Feeding. Globally, the most regulated class of genes was
the one coding for proteolytic enzymes, particularly the
serine-protease type. This group of proteases is highly
represented in nature and shows numerous and functionally
diverse functions, ranging from digestion and coagulation to
apoptosis and immunity [34]. In addition to the digestion-
related genes described above, feeding regulated two other
transcripts coding for highly important serine proteases,
namely kallikrein and furin. EST kallikrein 1 was speciﬁcally
regulated by HF 3h compared to LF, whereas furin was
downregulated at LF 1h. These two molecules act as
proprotein convertases in distinct regulatory pathways. The
ﬁrstcleaveskininogentoproducekininpeptide[35],whereas
furin processes the precursors of a large variety of proteins,
including growth factors and receptors [36]. Interestingly,
the speciﬁc pathways involving kallikrein-kinin [37, 38]
and other proteins of furin family [39, 40] are presently
being studied for their potential contribution to obesity and
cardiovascular disorders.
5. Conclusion
The present study was the ﬁrst to analyze the global
transcriptional changes acutely induced in mouse stomach
mucosa by feeding and, in particular, by diﬀerent nutritional
stimuli. The principal aim was to identify new signals
speciﬁcally induced by HF intake in the short term of
meal consumption. Given the weakest satiation power of
HF compared to LF foods, these signals may represent
potential pharmacological targets for the early modulation
of appetite/satiety balance. In this study, both LF and HF
regulated gene expression in gastric mucosa, and 17 known
genes were diﬀerentially modulated by HF compared to LF
intake. In addition, a number of novel tags were signiﬁcantly
r e g u l a t e d ,s o m eo fw h i c hm a yb eg o o do b j e c t sf o rf u t u r e
characterization studies. However, a lower number of genes
was regulated in the stomach compared to duodenum, when
the same experimental conditions have been applied [13].
This may suggest that gastric mucosa has a restricted role in
the acute regulation of food intake and mainly centered on
meal initiation than meal size/termination control. Another
plausible hypothesis is that satiation signals eventually rais-
ing from the mucosa could be induced earlier than 30min
after the beginning of the meal, at least at the transcriptional
level. Although it is still uncertain whether gastric mucosa
releases an early molecular signal speciﬁcally involved in
satiation control, the present study contributed to highlight
some potential mediators of this process. In addition, the
characterization of novel regulated genes could stimulate
futureinvestigations.Sincesignalssecretedbygastricmucosa
may be the optimal targets for appetite control and obesity
therapeutic strategies, further research eﬀorts are deserved.
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